Deborah Penque - Concepedia

Author

Deborah Penque

National Institute of Health Dr. Ricardo Jorge ORCID

Also Known As

D Penque, D. Penque, Deborah PENQUE, Deborah Penque, Penque, Deborah

120

Publications

2.5K

Citations

H-Index

118

Concepts

All Affiliations

National Institute of Health Dr. Ricardo Jorge University of Lisbon Universidade Nova de Lisboa Hospital de Santa Maria Instituto Gulbenkian de Ciência

About

Deborah Penque is an author at National Institute of Health Dr. Ricardo Jorge specializing in medicine, pathology, and molecular diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	26	1.5K
2	Natural Sciences	9	9	516
3	Engineering	5	5	324
4	Public Health	2	2	31
5	Social Sciences	1	1	219

Deborah Penque

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies Hugo Vicente Miranda, Éva M. Szegő, Luís M. A. Oliveira, Brain Neurochemical BiomarkersSynaptic SignalingSocial Sciencesα-Synuclein MisfoldingDegenerative Pathology	2017	219
The mechanism of sirtuin 2–mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease Rita Machado de Oliveira, Hugo Vicente Miranda, Laetitia Francelle, PLoS Biology MitophagySirtuin GenesImmunologyCell DeathMolecular Biology	2017	212
Five Percent of Normal Cystic Fibrosis Transmembrane Conductance Regulator mRNA Ameliorates the Severity of Pulmonary Disease in Cystic Fibrosis Anabela S. Ramalho, Sebastian Beck, Michelle E. Meyer, American Journal of Respiratory Cell and Molecular Biology EngineeringInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationGenetics	2002	176
The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70 Carlos M. Farinha, Paulo Nogueira, Filipa Mendes, Biochemical Journal Protein SecretionMolecular BiologyCellular PhysiologyProtein FoldingVivo Stabilization	2002	132
Sequence of one α- and two β-tubulin genes of Tetrahymena pyriformis Isabel Barahona, Helena Soares, Luísa Cyrne, Journal of Molecular Biology BiologyBiosynthesisPhylogeneticsBiochemical TaxonomyNatural Sciences	1988	100
Cystic Fibrosis F508del Patients Have Apically Localized CFTR in a Reduced Number of Airway Cells Deborah Penque, Filipa Mendes, Sebastian Beck, Laboratory Investigation	2000	99
Evaluation of the Clinical Significance of <i>homB,</i> a Novel Candidate Marker of <i>Helicobacter pylori</i> Strains Associated with Peptic Ulcer Disease Mónica Oleastro, Rita Cordeiro, Jonathan Ferrand, The Journal of Infectious Diseases	2008	79
Proteomic analysis of nasal cells from cystic fibrosis patients and non‐cystic fibrosis control individuals: Search for novel biomarkers of cystic fibrosis lung disease Mónica Roxo‐Rosa, Gonçalo da Costa, Theo M. Luider, PROTEOMICS Inflammatory Lung DiseaseLung InflammationPathologyProteomic TechnologyRespiratory Toxicology	2006	73
Cystic fibrosis patients with the 3272-26A?G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane Sebastian Beck, Deborah Penque, Susana M. D. A. Garcia, Human Mutation Inflammatory Lung DiseaseGeneticsPathologyGene CharacterizationMolecular Genetics	1999	73
Two‐dimensional gel electrophoresis and mass spectrometry for biomarker discovery Deborah Penque PROTEOMICS - CLINICAL APPLICATIONS EngineeringImmunologyProteome ProjectCandidate Disease BiomarkersProteomic Technology	2008	64

Page 1